Evolus Inc
Change company Symbol lookup
Select an option...
EOLS Evolus Inc
ADI Analog Devices Inc
BAC Bank of America Corp
CLOV Clover Health Investments Corp
HRL Hormel Foods Corp
DD Dupont De Nemours Inc
PSRU Valiant Eagle Inc
CRM Salesforce.Com Inc
VLYPP Valley National Bancorp
FEMKX Fidelity® Emerging Markets Fund
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Evolus, Inc. is a medical aesthetics company. The Company is focused on providing physicians and aesthetic procedures and treatments. It also focuses on offering the self-pay aesthetic market and its product candidate, PrabotulinumtoxinA (DWP-450), is an injectable 900 kilodalton, or kDa, botulinum toxin type designed to address the needs of the large and growing facial aesthetics market. It offers physicians and patients a compelling value proposition with DWP-450. OnabotulinumtoxinA (BOTOX) is the neurotoxin approved 900 kDa botulinum toxin type A complex in the United States.

Postmarket

Last Trade
Delayed
$14.26
0.24 (1.71%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$14.02
Day's Change
1.51 (12.07%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
14.50
Day's Low
12.83
Volume
(Light)
Volume:
1,498,777

10-day average volume:
4,533,404
1,498,777

Company Profile

Evolus, Inc. is a medical aesthetics company. The Company is focused on providing physicians and aesthetic procedures and treatments. It also focuses on offering the self-pay aesthetic market and its product candidate, PrabotulinumtoxinA (DWP-450), is an injectable 900 kilodalton, or kDa, botulinum toxin type designed to address the needs of the large and growing facial aesthetics market. It offers physicians and patients a compelling value proposition with DWP-450. OnabotulinumtoxinA (BOTOX) is the neurotoxin approved 900 kDa botulinum toxin type A complex in the United States.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
7.62x
Price/Book (MRQ)
12.03x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

February 2021
Current Month
3.3M
Previous Month
3.7M
Percent of Float
15.20%
Days to Cover
5.7848 Days

Share Information

EOLS is in a share class of common stock
Float
21.7M
Shares Outstanding
33.7M
Institutions Holding Shares
110
23.12%

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • Vikram MalikChmn.
  • David MoatazediPres.
  • Lauren P. SilvernailCFO
  • Jeff PlumerCounsel
  • Rui L. AvelarOther

Address

  • 520 Newport Center Dr Ste 1200
  • Newport Beach, CA 92660-7022
  • Phone: (949) 284-4555
  • Fax: (302) 636-5454
  • https://www.evolus.com

Insider Trading

During the most recent quarter, 16K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.